Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival
about
Statins Are Associated With Reduced Mortality in Multiple Myeloma.Statins and breast cancer prognosis: evidence and opportunities.Low-dose aspirin and survival from lung cancer: a population-based cohort studyAssociations between diabetes medication use and risk of second breast cancer events and mortalityRecent prediagnostic aspirin use, lymph node involvement, and 5-year mortality in women with stage I-III breast cancer: a nationwide population-based cohort studyStatin use and breast cancer survival: a nationwide cohort study in Scotland.Weight Gain After Breast Cancer Diagnosis and All-Cause Mortality: Systematic Review and Meta-Analysis.Myelodysplastic syndrome and acute myeloid leukemia following adjuvant chemotherapy with and without granulocyte colony-stimulating factors for breast cancer.Breast cancer recurrence in relation to antidepressant use.Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts.Patterns of statin initiation and continuation in patients with breast or colorectal cancer, towards end-of-life.Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature.Pre-diagnostic statin use, lymph node status and mortality in women with stages I-III breast cancer.Statin use and mortality among ovarian cancer patients: A population-based cohort study.Evidence for Detection Bias by Medication Use in a Cohort Study of Breast Cancer Survivors.Effect of low-dose aspirin use on survival of patients with gastrointestinal malignancies; an observational study.De novo post-diagnosis statin use, breast cancer-specific and overall mortality in women with stage I-III breast cancerDigoxin use after diagnosis of prostate cancer and survival: a population-based cohort study.Commonly used medications and endometrial cancer survival: a population-based cohort study.Comparative safety of pioglitazone versus clinically meaningful treatment alternatives concerning the risk of bladder cancer in older US adults with type 2 diabetes.Clopidogrel use and cancer-specific mortality: a population-based cohort study of colorectal, breast and prostate cancer patients.Digoxin use after diagnosis of breast cancer and survival: a population-based cohort study.The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes.The effect of warfarin therapy on breast, colorectal, lung, and prostate cancer survival: a population-based cohort study using the Clinical Practice Research Datalink.Pre-diagnostic anthropometry and survival after colorectal cancer diagnosis in Western European populations.Statin use is associated with improved survival in ovarian cancer: A retrospective population-based study.Aspirin use and ovarian cancer mortality in a Danish nationwide cohort study.Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort study.Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study.Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990-2010.Targeting Tumor Metabolism With Statins During Treatment for Advanced-stage Pancreatic Cancer.Acetaminophen, antibiotics, ear infection, breastfeeding, vitamin D drops, and autism: an epidemiological study.Association between post-diagnostic use of cholera vaccine and risk of death in prostate cancer patients.
P2860
Q33816591-F698DB00-26FC-4D12-A41A-2312B4D89FB9Q34206487-A57E7E20-775E-4129-892F-6474B730A5ABQ35843033-89EC0E9B-AA03-4252-B3DA-B74FBC6A63B9Q35850213-43C10E28-BDB4-4B2B-8679-B5F2A7CAE08EQ35911030-A46846FB-93D4-4D41-86E5-8DAC2119B975Q36095264-3C91FDA9-21F3-4428-A78F-BBC8568F0080Q36468884-A973E5BA-A3BA-44AC-B70F-D1EE3C8EFF21Q36479390-BD5577D6-5AB0-425E-87BA-CF319C97D734Q37020150-0E5CBEAD-7456-4B84-B8B4-08614195DBA6Q37465305-DD247D0F-67E2-4B32-8FD1-99BDE3E0896BQ37736058-5257B858-D559-48E5-9300-73E564C32D27Q38226775-8E4AF1D6-831A-4FF0-8CBC-449F395161CBQ38673155-64909B5F-2DC2-45A1-A21E-A30D334945D2Q38836074-F785434A-1598-4516-8660-21B381E549DDQ38879569-3A21AC53-EE1D-43D6-B069-57B28B2B9C60Q39029165-2CED3739-1556-4C1C-AC40-FC371CB9EB54Q39534421-0356DB88-D727-42E5-839A-D1DBFFFEBDAAQ39794208-EEE089F0-914A-4EBF-8863-1370EC4AD042Q40132826-0AAF77B7-2BF3-4AB5-83A4-9CF54DA4574AQ40141299-424839FE-7C7F-4179-B41F-7C825D54722AQ40897159-A72FF23E-83C2-45D0-A129-0137DA04E5F2Q40938507-4A1C53D9-C59D-49FC-85B5-FB204A8FFAFFQ41241629-AA9412B6-936F-43E9-B8DE-E73C8E562F76Q41656424-21103153-C5F4-4E0D-A8C3-8FCD85784AACQ44054901-EC1E9314-AAAD-4C49-8343-30F361612D8AQ47119934-353DBE2A-5F51-4567-AAD1-74F822AC173BQ47190426-B18E8BB6-CCD7-4D14-ACBF-ECEAF4F25FC2Q47626689-3F73EF7C-119C-448F-AE48-33AD999BDA61Q47651513-EE9ED9A7-9A32-432C-947D-47068F3A8D8DQ49517068-A1107972-F2D2-4106-921F-72B0716367ACQ53273637-A0C74301-02D6-431B-BA3D-8488F6CDBF36Q55223206-41354601-BAA9-473F-83B0-D0339A945034Q55285043-ABB6E599-99B4-4DA7-8B65-FE1188F4E5FA
P2860
Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Threats to validity of nonrand ...... cancer recurrence and survival
@ast
Threats to validity of nonrand ...... cancer recurrence and survival
@en
Threats to validity of nonrand ...... cancer recurrence and survival
@nl
type
label
Threats to validity of nonrand ...... cancer recurrence and survival
@ast
Threats to validity of nonrand ...... cancer recurrence and survival
@en
Threats to validity of nonrand ...... cancer recurrence and survival
@nl
prefLabel
Threats to validity of nonrand ...... cancer recurrence and survival
@ast
Threats to validity of nonrand ...... cancer recurrence and survival
@en
Threats to validity of nonrand ...... cancer recurrence and survival
@nl
P2093
P2860
P3181
P356
P1476
Threats to validity of nonrand ...... cancer recurrence and survival
@en
P2093
B. McKnight
D. M. Boudreau
H. S. Wirtz
N. S. Weiss
P2860
P304
P3181
P356
10.1093/JNCI/DJT211
P407
P577
2013-10-02T00:00:00Z